利索-全球专利检索

  1. 登录
  2. 注册
发明授权
CN102048987B 一种治疗急性粒细胞AML-M3型白血病的中药组合物 失效 - 权利终止

一种治疗急性粒细胞AML-M3型白血病的中药组合物
摘要：
一种治疗急性粒细胞AML-M3型白血病的中药组合物，它由下述组分组成：生地15～25克、牡丹皮8～16克、蜜炙粉甘草（甘草）4～8克、白花蛇草（白花蛇舌草）18～32克、白茅根14～20克、女贞子18～28克、肉苁蓉14～28克、冬虫夏草4～8克、当归15～25克、鸡血藤15～25克、土茯苓11～21克。本发明的药物针对急性粒细胞白血病的具体分型AML—M3型进行针对性治疗，有选择性的抑制和杀灭幼稚细胞，诱导白血病细胞凋亡，针对性更强，治疗效果更高。促进白血病细胞的分化、成熟。调节气血，增强免疫功能。促进骨髓正常造血功能的恢复。减少逆转，防止耐药的产生。减少化疗的毒副作用，增强体质。
摘要（英）：

The invention provides a traditional Chinese medicine composition for treating acute myeloblastic leukemia (AML) M3. The composition is prepared from the following components: 15-25g of radix rehmanniae, 8-16g of cortex moutan, 4-8g of honey-fried liquorice powder, 18-32g of oldenlandia diffusa, 14-20g of lalang grass rhizome, 18-28g of glossy privet fruit, 14-28g of herba cistanche, 4-8g of cordyceps sinensis, 15-25g of angelica, 15-25g of suberect spatholobus stem and 11-21g of glabrous greenbrier rhizome. The medicine provided by the invention has the following functions: pertinently treating specific AML-M3, selectively inhibiting and killing immature cells, inducing leukemia cell apoptosis and having stronger pertinence and higher treatment effect; promoting differentiation and maturity of leukemia cells; regulating qi and blood and enhancing immunity; promoting recovery of normal hematopoietic function of marrows; reducing reversion and preventing medicine resistance; and reducing toxic or side effects of chemotherapy and strengthening physique.

公开/授权文献
0/0